BNP Paribas Financial Markets’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.4M | Buy |
|
|||||
|
2025
Q2 | $11.8M | Buy |
|
|||||
|
2025
Q1 | $5.01M | Buy |
|
|||||
|
2024
Q4 | $3.43M | Sell |
|
|||||
|
2024
Q3 | $4.82M | Buy |
|
|||||
|
2024
Q2 | $1.62M | Buy |
|
|||||
|
2024
Q1 | $909K | Sell |
|
|||||
|
2023
Q4 | $1.34M | Buy |
|
|||||
|
2023
Q3 | $1.2M | Sell |
|
|||||
|
2023
Q2 | $1.11M | Sell |
|
|||||
|
2023
Q1 | $1.36M | Buy |
|
|||||
|
2022
Q4 | $524K | Buy |
|
|||||
|
2022
Q3 | $139K | Sell |
|
|||||
|
2022
Q2 | $164K | Sell |
|
|||||
|
2022
Q1 | $608K | Buy |
|
|||||
|
2021
Q4 | $670K | Buy |
|
|||||
|
2021
Q3 | $64.2K | Buy |
|
|||||
|
2021
Q2 | $15K | Sell |
|
|||||
|
2021
Q1 | $64.8K | Buy |
|
|||||
|
2020
Q4 | $54.5K | Sell |
|
|||||
|
2020
Q3 | $97.9K | Buy |
|
|||||
|
2020
Q2 | $35.3K | Sell |
|
|||||
|
2020
Q1 | $70.1K | Buy |
|
|||||
|
2019
Q4 | $24.8K | Buy |
|
|||||
|
2019
Q3 | $18.9K | Buy |
|
|||||
|
2019
Q2 | $20.8K | Sell |
|
|||||
|
2019
Q1 | $48.5K | Buy |
|
|||||
|
2018
Q4 | $6.12K | Buy |
|
|||||
|
2018
Q3 | $3.52K | Buy |
|